Scarica l'app Stockscreener
1.04
1.89%
-0.02
Dopo l'orario di chiusura:
1.06
0.02
+1.92%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Ww International Inc Borsa (WW) Ultime notizie
WeightWatchers' CEO embraced Ozempic. Now she's out of the company. - AOL
WW (WW International) GF Score : 51/100 (As of Oct. 30, 2024) - GuruFocus.com
WW (WW International) Profitability Rank : 6 (As of Jun. 2024) - GuruFocus.com
WW International (WW) Scheduled to Post Earnings on Wednesday - MarketBeat
WW International, Inc. (NASDAQ:WW) Short Interest Up 20.4% in October - MarketBeat
WeightWatchers cashes in on popularity of weight loss drugs with compounded semaglutide - MSN
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call - The Manila Times
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More - GlobeNewswire Inc.
WW International, Inc. (NASDAQ:WW) Receives $4.50 Consensus Target Price from Analysts - MarketBeat
WW International (WW) Stock Rises on Potential Reconsideration o - GuruFocus.com
WW surge after GLP-1 compounding announcement not justified after study, Barclays says - MSN
WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model' - Yahoo Finance
WW International (NASDAQ:WW) Given Underweight Rating at Barclays - MarketBeat
A company insider recently bought 64,500 shares of WW International Inc [WW]. Should You Buy? - Knox Daily
Analysts Reiterate Negative Outlook on WeightWatchers (NASDAQ:WW) Stock - TipRanks
Weight Watchers Stock Rises 38% On Plan To Sell Obesity Drugs - Baystreet.ca
WW International: The Party Won't Last Long (NASDAQ:WW) - Seeking Alpha
WW Stock Rises as WeightWatchers Expands Drug Offerings - GuruFocus.com
WW International Inc (WW) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
WW International Inc (WW) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
WeightWatchers (NASDAQ:WW) Stock Jumps 40% on Plan to Sell Obesity Medications - TipRanks
Why Are WeightWatchers (WW) Shares Soaring Today - Yahoo Finance
WW International surges as Morgan Stanley says GLP-1 entry 'not too late' - MSN
Traders Purchase High Volume of Call Options on WW International (NASDAQ:WW) - MarketBeat
Perhaps timely catching WW International Inc (WW) would be a good idea - SETE News
WW International (WW) Surges After Introducing Compounded Semagl - GuruFocus.com
WW International surges as Morgan Stanley says GLP-1 entry 'not too late' (WW) - Seeking Alpha
What's Going With WeightWatchers Stock On Wednesday? - Yahoo Finance
Market Analysts see WW International Inc [WW] falling to $1.25. Time to buy? - The DBT News
WW International, Inc. (NASDAQ:WW) Stock Catapults 54% Though Its Price And Business Still Lag The Industry - Simply Wall St
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy - Fast Company
WW International shares face pressure as Barclays flags concerns over long-term viability of compounding - Investing.com South Africa
WW’s Stock Journey: What Investors Need to Know About WW International Inc’s Performance - The InvestChronicle
WeightWatchers Stock Soars on Copycat Weight-Loss Drug Offering - Investopedia
WeightWatchers stock pops on compounded GLP-1 weight-loss medication - Yahoo Finance
WeightWatchers Jumps on Offer to Sell Low-Cost Wegovy Copy - Bloomberg
WeightWatchers adds semaglutide for weight management By Investing.com - Investing.com UK
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to offering - MarketWatch
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications - StockTitan
3.61%
14.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):